Global Business Partner Intelligence
Verify a third party’s corporate information and associates.
Be alerted to critical changes throughout your engagement.
Premium Corporate Data
Ensure you have the third-party corporate intelligence needed to drive informed decisions. Ethixbase360 empowers and protects your business with accurate and up-to-date premium corporate data curated from tens of thousands of sources with hundreds of millions of business records at your disposal.
Leverage Ethixbase360’s Premium Corporate Data to:
- Confirm business status
- Conduct Know Your Third-Party verification
- Identify & screen directors and executives
- Make decisions informed by accurate and validated data
- Monitor third parties to be informed when key business data changes and take proactive steps to protect your business
Gain powerful third-party insights to better understand business partners and protect against risk
- Premium Corporate Data is available for over 500million entities spanning over 220 countries
- Benefit from over 5 million daily updates to ensure that business data is as up-to-date and accurate as possible
- Verify entity address, registration, industry, directors and executives with a standardized dataset
- Monitor and be alerted to changes in company details, ownership status or individual associations
- Find associated individuals or entities such as directors and executives and select these for additional and ongoing risk-based screening against sanctions, adverse media and political exposure
Download the Brochure
Verify third-party company information, directors, and executives to make informed decisions and be alerted to changes over time. Download here.
© 2023 Dun & Bradstreet. All Rights Reserved
Ready to get started?
Resources
Our Latest News, Case Studies, Webinars & More

AMERS
Ownership Transparency and Sanctions Risk: Building a Defensible UBO Program
Ultimate beneficial ownership (UBO) has moved from a background AML requirement to a central control for sanctions compliance, export controls, and third-party risk management. [...]
AMERS
Reputational Risk and Third-Party Exposure: Compliance Lessons from the Epstein Files
Recent disclosures linked to the Epstein case have reignited public scrutiny around reputational risk, third-party relationships, and the hidden vulnerabilities that sit beyond formal contracts [...]
Blog
Key Takeaways from Our London Roundtable: Human Rights Due Diligence in Pharma
We recently hosted a pharma-focused roundtable in partnership with Norton Rose Fulbright at their London office, bringing together senior risk and compliance professionals from across the life sciences industry. [...]
Blog
Economic Pressure, Perverse Incentives, and the Growing Importance of Third-Party Risk Management
The ongoing conflict in Iran has added fresh volatility to an already fragile global economic outlook in 2026, compounding uncertainty around tariffs, sanctions, and wider geopolitical tensions. [...]
APAC
Melbourne Seminar: Integrating Human Rights into Third-Party Risk Management: From Onboarding to Continuous Monitoring
Artificial intelligence is increasingly used in third-party risk management to help organizations manage scale, data volume, and ongoing monitoring requirements. [...]
Compliance Insights